行情

RDUS

RDUS

Radius Health
NASDAQ

实时行情|Nasdaq Last Sale

28.94
+0.08
+0.28%
交易中 10:41 09/20 EDT
开盘
28.89
昨收
28.86
最高
29.20
最低
28.55
成交量
19.00万
成交额
--
52周最高
29.97
52周最低
12.81
市值
13.35亿
市盈率(TTM)
-7.8166
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

RDUS 新闻

  • 加拿大FirstQuantum正吸引全球矿业企业初步收购兴趣
  • 新浪美股.20分钟前
  • 戴姆勒停止内燃机研发闹乌龙?网上现两个版本说法
  • 新京报.25分钟前
  • iPhone 11线下开售:普通配色现场可买 暗夜绿断货
  • 澎湃新闻.57分钟前
  • 瑞信:美国股票面临170亿美元的退休基金卖盘
  • 新浪财经综合.58分钟前

更多

所属板块

生物技术和医学研究
+0.74%
制药与医学研究
+1.16%

热门股票

名称
价格
涨跌幅

RDUS 简况

Radius Health, Inc. is a biopharmaceutical company. The Company is focused on the developing therapeutics in the areas of osteoporosis, oncology and endocrine diseases. The Company's lead investigational product candidate, TYMLOS (abaloparatide-SC) injection is developed for the treatment of postmenopausal women with osteoporosis at high risk for fracture. The Company’s clinical pipeline also includes an investigational abaloparatide transdermal patch for potential use in osteoporosis and the investigational drug elacestrant (RAD1901) for potential use in hormone-driven and/or hormone-resistant breast cancer, and vasomotor symptoms in postmenopausal women. Its RAD140 is a non-steroidal, selective androgen receptor modulator (SARM). RAD140 is under development for potential use in hormone receptor positive breast cancer.
展开

Webull提供Radius Health Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。